Drug Shortage Report for TARO-GLICLAZIDE MR
Report ID | 169507 |
Drug Identification Number | 02439328 |
Brand name | TARO-GLICLAZIDE MR |
Common or Proper name | GLICLAZIDE |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | GLICLAZIDE |
Strength(s) | 60MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-12-07 |
Estimated end date | 2024-07-28 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-06-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v40 | 2024-06-14 | French | Compare |
v39 | 2024-06-14 | English | Compare |
v38 | 2024-05-07 | French | Compare |
v37 | 2024-05-07 | English | Compare |
v36 | 2024-03-13 | French | Compare |
v35 | 2024-03-13 | English | Compare |
v34 | 2024-03-01 | French | Compare |
v33 | 2024-03-01 | English | Compare |
v32 | 2024-01-05 | French | Compare |
v31 | 2024-01-05 | English | Compare |
v30 | 2023-10-25 | French | Compare |
v29 | 2023-10-25 | English | Compare |
v28 | 2023-08-16 | French | Compare |
v27 | 2023-08-16 | English | Compare |
v26 | 2023-07-18 | French | Compare |
v25 | 2023-07-18 | English | Compare |
v24 | 2023-06-09 | French | Compare |
v23 | 2023-06-09 | English | Compare |
v22 | 2023-04-10 | French | Compare |
v21 | 2023-04-10 | English | Compare |